Table 1.
Dose modification for nonhematological and hematological toxicities should take place upon improvement to grade 1 toxicity or return to baseline (recovery). | |
First occurrence | Restart at 420 mg/day |
Second occurrence | Restart at 280 mg/day |
Third occurrence | Restart at 140 mg/day |
Fourth occurrence | Discontinue ibrutinib |